Literature DB >> 18265688

Bacteria and salivary profile of adolescents with and without cleft lip and/or palate undergoing orthodontic treatment.

L L Cheng1, S L Moor, O Kravchuk, I A Meyers, C T C Ho.   

Abstract

BACKGROUND: Patients with cleft lip and/or palate (CL&/P) experience a higher caries prevalence. This study aimed to determine if patients with CL&/P, undergoing and not undergoing orthodontic treatment, have a different salivary biochemical profile and different salivary levels of Mutans Streptococci (MS) and Lactobacilli (LB) compared to patients undergoing and not undergoing orthodontic treatment without CL&/P.
METHODS: One hundred and ten subjects aged between 12 and 17 years were recruited into one of four different groups comprising two control groups and two treatment groups. The control groups comprised of subjects with and without CL&/P who were not undergoing orthodontic treatment. The treatment groups comprised of subjects with and without CL&/P undergoing orthodontic treatment. Regular reinforcement of oral hygiene instructions, dietary counselling and debridement, when necessary, were offered to subjects in the treatment groups following their orthodontic adjustment appointments. The salivary secretion time, pH of resting and stimulated saliva, salivary flow rate, buffering capacity, quantity of salivary MS and LB were measured.
RESULTS: Subjects with CL&/P undergoing orthodontic treatment at the Children's Oral Health Service tended to present with microbiological and salivary profiles that were less favourable for caries development. There was a significant difference in the percentage of subjects with > or = 10(5) colony forming units (CFU)/mL of MS between the cleft treatment and non-cleft treatment groups. Subjects in the non-cleft treatment group had the highest percentage of subjects (86.7 per cent) with > or = 10(5) CFU/mL of MS whereas subjects in the cleft treatment group had the lowest percentage of subjects (60 per cent) with > or = 10(5) CFU/mL of MS. For LB, there were significantly higher percentages of subjects with > or =10(5) CFU/mL of LB in the non-cleft treatment (76.7 per cent) and cleft treatment (73.3 per cent) groups compared to the non-cleft control (46.7 per cent) and cleft control (40.0 per cent) groups.
CONCLUSIONS: Regular oral hygiene reinforcement and dental health education appears to have a positive effect in reducing the percentage of subjects with > or = 10(5) CFU/mL of MS.

Entities:  

Mesh:

Year:  2007        PMID: 18265688     DOI: 10.1111/j.1834-7819.2007.tb00508.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  6 in total

Review 1.  One-to-one dietary interventions undertaken in a dental setting to change dietary behaviour.

Authors:  Rebecca Harris; Ana Gamboa; Yvonne Dailey; Angela Ashcroft
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

2.  Salivary microbial profiles in 5-year old children with oral clefts: a comparative study.

Authors:  A L Sundell; C Ullbro; G Dahlén; A Marcusson; S Twetman
Journal:  Eur Arch Paediatr Dent       Date:  2018-02-01

3.  Caries risk factors in children under treatment with sectional brackets.

Authors:  Sugako Sanpei; Toshiya Endo; Shohachi Shimooka
Journal:  Angle Orthod       Date:  2010-05       Impact factor: 2.079

Review 4.  Are people with an orofacial cleft at a higher risk of dental caries? A systematic review and meta-analysis.

Authors:  V Worth; R Perry; T Ireland; A K Wills; J Sandy; A Ness
Journal:  Br Dent J       Date:  2017-07-07       Impact factor: 1.626

5.  Influence of sport mouthguards on the ecological factors of the children oral cavity.

Authors:  Simonetta D'Ercole; Diego Martinelli; Domenico Tripodi
Journal:  BMC Oral Health       Date:  2014-08-05       Impact factor: 2.757

6.  Effect of fixed orthodontic appliances on salivary properties.

Authors:  Giulio Alessandri Bonetti; Serena Incerti Parenti; Giulia Garulli; Maria Rosaria Gatto; Luigi Checchi
Journal:  Prog Orthod       Date:  2013-06-18       Impact factor: 2.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.